Healthcare
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Chimerix. United States. Announced Date 11/04/2013. Closed Date 16/04/2013. Deal value: $102m. Initial Public Offering. Industry: Chimerix is a biopharmaceutical company focused on developing antiviral therapies.